On the public citation graph

Liver Stiffness, Liver Function and Subsequent Metabolic Syndrome in NAFLD Associated Subclinical Atherosclerosis: Perspective from Mediation Analysis

0 signed · 57 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamanetworkopen.2019.12565openalex-extracted
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1001/jamanetworkopen.2022.34862openalex-extracted
Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife
inferredcites →https://doi.org/10.1002/hep.32072openalex-extracted
Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
inferredcites →https://doi.org/10.1002/hep.32519openalex-extracted
Risk of cardiovascular disease and loss in life expectancy in NAFLD
inferredcites →https://doi.org/10.1007/s10654-022-00868-3openalex-extracted
Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
inferredcites →https://doi.org/10.1016/j.arr.2022.101833openalex-extracted
Emerging role of aging in the progression of NAFLD to HCC
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2014.11.021openalex-extracted
Relationships of elevated levels of serum hepatic enzymes and alcohol intake with arterial stiffness in men
inferredcites →https://doi.org/10.1016/j.cell.2021.04.015openalex-extracted
Mechanisms and disease consequences of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.cgh.2022.04.014openalex-extracted
Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1016/j.jacc.2021.04.059openalex-extracted
Triglycerides and Residual Atherosclerotic Risk
inferredcites →https://doi.org/10.1016/j.jhep.2008.06.012openalex-extracted
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
inferredcites →https://doi.org/10.1016/j.jhep.2014.11.024openalex-extracted
The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease
inferredcites →https://doi.org/10.1016/j.jhep.2016.09.022openalex-extracted
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
inferredcites →https://doi.org/10.1016/j.jhep.2023.03.040openalex-extracted
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
inferredcites →https://doi.org/10.1016/j.metabol.2021.154779openalex-extracted
The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
inferredcites →https://doi.org/10.1016/j.plipres.2021.101109openalex-extracted
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
inferredcites →https://doi.org/10.1016/s0140-6736(20)32511-3openalex-extracted
Non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s2468-1253(21)00020-0openalex-extracted
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
inferredcites →https://doi.org/10.1038/s41569-021-00607-3openalex-extracted
Epidemiology of cardiovascular disease in Europe
inferredcites →https://doi.org/10.1038/s41591-018-0104-9openalex-extracted
Mechanisms of NAFLD development and therapeutic strategies
inferredcites →https://doi.org/10.1038/s41598-018-29639-5openalex-extracted
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
inferredcites →https://doi.org/10.1038/s41598-018-34913-7openalex-extracted
Serum Gamma-Glutamyltransferase Levels are Associated with Cardiovascular Risk Factors in China: A Nationwide Population-Based Study
inferredcites →https://doi.org/10.1038/s41598-023-35733-0openalex-extracted
Transition patterns of metabolic dysfunction-associated fatty liver disease status in relation to arterial stiffness progression: a health check-up cohort study
inferredcites →https://doi.org/10.1053/j.gastro.2016.06.001openalex-extracted
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
inferredcites →https://doi.org/10.1053/j.gastro.2020.01.043openalex-extracted
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1055/a-1930-6658openalex-extracted
Shared Mechanisms between Cardiovascular Disease and NAFLD
inferredcites →https://doi.org/10.1080/07853890.2021.1974081openalex-extracted
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China
inferredcites →https://doi.org/10.1080/10409238.2021.1925217openalex-extracted
Cholesterol efflux pathways, inflammation, and atherosclerosis
inferredcites →https://doi.org/10.1080/21655979.2021.1933302openalex-extracted
The association between hypertension and nonalcoholic fatty liver disease (NAFLD): literature evidence and systems biology analysis
inferredcites →https://doi.org/10.1093/eurheartj/ehaa238openalex-extracted
Genetic aetiology of blood pressure relates to aortic stiffness with bi-directional causality: evidence from heritability, blood pressure polymorphisms, and Mendelian randomization
inferredcites →https://doi.org/10.1093/eurheartj/ehab551openalex-extracted
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
inferredcites →https://doi.org/10.1097/cm9.0000000000002111openalex-extracted
Severity of non-alcoholic fatty liver disease is a risk factor for developing hypertension from prehypertension
inferredcites →https://doi.org/10.1097/hc9.0000000000000087openalex-extracted
Non-alcoholic fatty liver and fibrosis is associated with cardiovascular structure and function in young adults
inferredcites →https://doi.org/10.1097/meg.0000000000001353openalex-extracted
Elevated liver enzymes and cardiovascular mortality: a systematic review and dose–response meta-analysis of more than one million participants
inferredcites →https://doi.org/10.1097/meg.0000000000002299openalex-extracted
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.
inferredcites →https://doi.org/10.1109/rbme.2019.2931587openalex-extracted
Local Pulse Wave Velocity: Theory, Methods, Advancements, and Clinical Applications
inferredcites →https://doi.org/10.1111/apt.16324openalex-extracted
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/apt.17617openalex-extracted
Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/hepr.12688openalex-extracted
Hypertension and non‐alcoholic fatty liver disease proven by transient elastography
inferredcites →https://doi.org/10.1111/jgh.15871openalex-extracted
Gamma‐glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/liv.14322openalex-extracted
Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non‐invasive score
inferredcites →https://doi.org/10.1111/liv.15099openalex-extracted
Gamma‐Glutamyl Transferase (γ‐GT) – an old dog with new tricks?
inferredcites →https://doi.org/10.1161/cir.0000000000000950openalex-extracted
Heart Disease and Stroke Statistics—2021 Update
inferredcites →https://doi.org/10.1161/cir.0b013e3182009701openalex-extracted
Heart Disease and Stroke Statistics—2011 Update
inferredcites →https://doi.org/10.1161/circulationaha.120.046361openalex-extracted
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk
inferredcites →https://doi.org/10.1161/hypertensionaha.118.11212openalex-extracted
Interaction Between Hypertension and Arterial Stiffness
inferredcites →https://doi.org/10.1161/hypertensionaha.120.15220openalex-extracted
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories
inferredcites →https://doi.org/10.1186/s12872-018-0877-2openalex-extracted
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
inferredcites →https://doi.org/10.1186/s12944-018-0920-4openalex-extracted
AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study
inferredcites →https://doi.org/10.1186/s12944-020-01419-zopenalex-extracted
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study
inferredcites →https://doi.org/10.1186/s13098-021-00741-5openalex-extracted
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1186/s13098-023-01000-5openalex-extracted
Serum γ-glutamyltransferase level and incidence risk of metabolic syndrome in community dwelling adults: longitudinal findings over 12 years
inferredcites →https://doi.org/10.2147/ijgm.s319101openalex-extracted
Comparison of Visual Transient Elastography and Shear Wave Elastography in Evaluating Liver Fibrosis in Patients with Chronic Liver Disease
inferredcites →https://doi.org/10.3389/fphys.2021.762437openalex-extracted
Vascular Stiffness in Aging and Disease
inferredcites →https://doi.org/10.3390/ijms24086910openalex-extracted
Aging of the Arterial System
inferredcites →https://doi.org/10.3906/sag-1901-166openalex-extracted
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
inferredcites →https://doi.org/10.7570/jomes22021openalex-extracted
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.